MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently…
| Price | $21.77 |
|---|---|
| Market cap | $6.11B |
| Sector | Healthcare |
| Industry | Medical - Equipment & Services |
| Exchange | NASDAQ |
| 52-week range | 10.65-24.43 |
| Beta | -3.71 |
Explore MMED's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.